Sleep: the trials that measured what short sleep does to intake and to fat loss

Sleep is the lifestyle factor with the best controlled evidence and the least attention. Two studies do most of the work here.

Sleep extension reduced intake, measured objectively

Tasali and colleagues randomised 80 adults with overweight who habitually slept under 6.5 hours to either a single sleep-hygiene counselling session aimed at extending sleep, or no intervention, for two weeks in their own homes. Sleep was measured by wrist actigraphy and energy intake by the doubly labelled water method combined with body-composition change, so there were no food diaries to fudge. The extension group slept about 1.2 hours more per night and their energy intake fell by about 270 kcal per day relative to controls (PubMed 35129580). Nothing else was asked of them.

For someone on a GLP-1 that is a different lever from the drug: the drug lowers the drive to eat; adequate sleep removes one of the things that raises it.

Sleep restriction during a diet shifted the loss from fat to lean

Nedeltcheva's crossover study is small (10 adults) but tightly controlled. Each participant spent two 14-day periods on the same moderate calorie restriction in a laboratory, once with 8.5 hours in bed and once with 5.5. Total weight loss was the same in both conditions, about 3 kg. Its composition was not: with short sleep, fat loss fell by 55 percent (0.6 versus 1.4 kg) and fat-free mass loss rose by 60 percent (2.4 versus 1.5 kg). Hunger was higher and ghrelin rose with short sleep (PubMed 20921542).

The relevance to GLP-1 therapy is direct. The DXA substudies show a real lean-mass component in the weight lost. Short sleep is one of the things that makes that share larger.

How much

The American Academy of Sleep Medicine and Sleep Research Society consensus is 7 or more hours per night on a regular basis for adults aged 18 to 60, with less associated with weight gain and obesity among other outcomes (PubMed 26039963). This is a floor for most people, not a target to hit exactly.

Sleep apnea and GLP-1s

Obstructive sleep apnea is common in obesity and fragments sleep even when hours in bed are adequate. SURMOUNT-OSA randomised 469 adults with moderate-to-severe OSA and obesity to tirzepatide or placebo for 52 weeks; tirzepatide reduced the apnea-hypopnea index by about 25 to 29 events per hour versus about 5 to 6 with placebo, alongside weight loss of around 18 to 20 percent (PubMed 38912654). Two practical points follow. If you snore loudly, wake unrefreshed or have been told you stop breathing in your sleep, raise it with your prescriber: it is treatable and its treatment helps everything else. And if you already use CPAP, weight loss can change the pressure you need; ask about a review.

Practical notes for people on therapy

• Nausea and reflux are worse lying flat and worse after a late, large meal. A smaller earlier evening meal helps both sleep and symptoms (see eating on low appetite).
• Alcohol fragments sleep in the second half of the night in addition to its other effects (see alcohol).
• Night-time trips to the bathroom rise with higher fluid intake; front-load fluids earlier in the day rather than cutting them (see hydration and fibre).
• If a stall on the scale coincides with a stretch of short nights, that is the first thing to fix, not the dose (see plateaus).